Date Issued
|
Report Number
16-02940-183
No. 1
to Veterans Health Administration (VHA)
Closure Date: 1/14/2019
The Veterans Integrated Service Network 9 Director ensures that clinical reviews are completed on the patients discussed in this report to determine whether delays adversely affected patients’ clinical care, notifies patients of lapses in care as needed, and/or takes other action as appropriate.
No. 2
to Veterans Health Administration (VHA)
Closure Date: 11/26/2018
The James H. Quillen VA Medical Center Director improves and monitors mechanisms to track and recall patients who require surveillance colonoscopies.
No. 3
to Veterans Health Administration (VHA)
Closure Date: 11/26/2018
The James H. Quillen VA Medical Center Director improves and monitors mechanisms to track patients for whom a diagnostic colonoscopy after a positive fecal immunochemical test is indicated as required by Veterans Health Administration and James H. Quillen VA Medical Center policy.
No. 4
to Veterans Health Administration (VHA)
Closure Date: 11/26/2018
The James H. Quillen VA Medical Center Director improves efforts to ensure non-VA colonoscopy reports are available for viewing in patients’ VA electronic health records.
No. 5
to Veterans Health Administration (VHA)
Closure Date: 11/26/2018
The James H. Quillen VA Medical Center Director ensures that processes are in place to monitor providers’ compliance with Veterans Health Administration Colorectal Cancer Screening policy including the referral of the patient for a diagnostic colonoscopy after a positive fecal immunochemical test rather than a repeat fecal immunochemical test.
No. 6
to Veterans Health Administration (VHA)
Closure Date: 11/26/2018
The James H. Quillen VA Medical Center Director takes action to identify patients who submitted fecal immunochemical test kits that could not be processed and notifies these patients of a need to re-submit fecal immunochemical test specimens.
No. 7
to Veterans Health Administration (VHA)
Closure Date: 1/14/2019
The James H. Quillen VA Medical Center Director ensures that processes are strengthened to track and monitor the distribution of fecal immunochemical test kits to patients.